Luspatercept for the Treatment of Anemia in Non-Transfusion-Dependent β-Thalassemia: Final Safety and Efficacy Data from the BEYOND Trial
Year: 2023
Type: conference-abstract
Source: Blood
Authors: Ali T Taher, Vip Viprakasit, Antonis Kattamis, Silverio Perrotta, Paolo Ricchi, John B. Porter, Thomas D Coates, Gian Luca Forni, Khaled M. Musallam, Oriana Esposito, Ana Carolina Giuseppi, Wen-Ling Kuo, Marta Reverte, Richard Wei, Luciana Moro Bueno, Maria Domenica Cappellini
Institutions: American University of Beirut Medical Center, Mahidol University, National and Kapodistrian University of Athens, University of Campania "Luigi Vanvitelli", University College London, University of Southern California, Children's Hospital Los Angeles, Ente Ospedaliero Ospedali Galliera, Bristol-Myers Squibb (Switzerland), Bristol-Myers Squibb (United States), University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389234939
